FOLH1 and prostate cancer: Although mpMRI or PSMA PET provide a precise location of prostate cancer, for example, [18F]F-PSMA-1007 is excreted through the liver and can avoid the influence of urine retention in the bladder on the detection of lesions [10], they provide only graphic support.